NCT00001865View on ClinicalTrials.gov

HAT in Eye Complications of Behcet's Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

July 31, 1999

Study Completion Date

June 30, 2004

Conditions

Behcet's SyndromeRetinal DiseaseUveitis

Interventions

DRUG

Daclizumab

Trial Locations (1)

20892

National Eye Institute (NEI), Bethesda

All Listed Sponsors

lead

National Eye Institute (NEI)

NIH

NCT00001865 - HAT in Eye Complications of Behcet's Disease | Biotech Hunter | Biotech Hunter